Camp4 Therapeutics Ratios (2023-2026) | CAMP

Ratios Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -3,341.71%-2,036.66%-1,458.28%-840.01%-1,663.90%-3,467.24%-939.80%
EBIT Margin (Quarter) -3,525.14%-2,152.45%-1,526.81%-870.27%-1,717.11%-3,671.26%-1,010.12%
EBITDA Margin (Quarter) -3,341.71%-2,036.66%-1,449.07%-840.81%-1,899.25%-11,575.86%-1,416.62%
Operating Margin (Quarter) -3,525.14%-2,152.45%-1,526.81%-870.27%-1,717.11%-3,671.26%-1,010.12%
Net Margin (Quarter) -3,341.71%-2,036.66%-1,458.28%-840.01%-1,663.90%-3,467.24%-939.80%
FCF Margin (Quarter) -1,703.99%-1,665.03%-709.55%-1,410.94%1,794.83%-850.08%
Efficiency
Assets Average (Quarter) 49.84M70.54M57.02M68.83M102.10M111.63M
Equity Average (Quarter) -117.64M-129.53M-141.22M-153.04M-47.92M57.36M45.78M49.33M53.19M39.30M
Invested Capital (Quarter) -111.55M-123.73M-135.33M-147.11M-158.97M63.30M51.67M40.07M58.74M47.70M30.90M
Asset Utilization Ratio (Quarter) 0.010.020.050.060.030.04
Leverage & Solvency
Interest Coverage Ratio (Quarter) -262.51-162.36-218.0096.79
Equity Ratio (Quarter) -2.25-7.440.810.820.780.680.400.29
Times Interest Earned (Quarter) -262.51-162.36-218.0096.79
Valuation
Enterprise Value (Quarter) -50.47M-38.38M-2.53M-64.04M-49.30M-39.05M-75.30M-110.86M-99.94M
Return Ratios
Return on Sales (Quarter) -0.33%-1.42%-0.20%-0.15%-0.08%-0.17%-0.35%-0.09%
Return on Capital Employed (Quarter) -131.93%-83.17%-108.03%-88.32%-60.70%-55.29%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.01%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.01%-0.01%-0.01%-0.01%-0.01%-0.01%